Our leadership has the experience required to provide guidance and focus as we strive to help our customers succeed.
Dan Sullivan - President & CEO
Mr. Sullivan brings more than 35 years of experience as a medical device executive and entrepreneur to NeuWave. He was recently the President and CEO of SuperDimension, Inc., and led them from their early commercial expansion through their acquisition by Covidien Ltd. in 2012. Mr. Sullivan began his career at American Hospital Supply, Inc. and had his entrepreneurial start at SCIMED Life Systems, Inc. At SCIMED, Dan was Vice President of Sales and marketing and simultaneously GM of the Ancillary Division, and a key member of the executive team that built the company from zero to a market leading position in the field of angioplasty and interventional cardiology. SCIMED was sold to Boston Scientific, Inc. and remains a significant part of the company. Dan was subsequently involved as CEO, co-founder and Board member of numerous successful med-tech start-ups that have either sold or become public, including Vascular Science and Atritech which were acquired by St. Jude Medical and Boston Scientific respectively. He was also on the board of ACIST Medical, acquired by Bracco; NeoVision, acquired by U.S. Surgical; Quannum Medical, acquired by Boston Scientific; and Vascular Solutions that went public. Dan spends his spare time flying Mig fighter jets with "The Hoppers," the first civilian jet formation team, that he co-founded.
Chris Geyen – Chief Financial Officer
Mr. Geyen brings a 20-year track record of progressive leadership experience in fast-paced, rapidly growing public and private life science companies. Prior to joining NeuWave Medical, he served as the Chief Financial Officer of Celleration, a venture backed company focused on developing and commercializing therapeutic ultrasound healing technologies, through their acquisition by Alliqua BioMedical. Previously, he served as the Chief Financial Officer of Restore Medical, a manufacturer of innovative medical devices to treat sleep-disordered breathing, where he successful completed an initial public offering and the eventual sale of Restore to Medtronic. Mr. Geyen also previously served as Chief Financial Officer of Acorn Medical and Urologix and began his career at Ernst and Young. Mr. Geyen holds a Bachelor’s degree in Business Administration and Accounting from the University of St. Thomas – St. Paul, MN. Mr. Geyen is also a licensed CPA (Inactive).
Mike Blue - Vice President Sales
Mr. Blue brings over 18-years of sales experience and 15 in med device almost exclusively in interventional oncology, and previous 12-years in leadership positions. Prior to joining NeuWave, Mr. Blue served as Vice President of Sales at Covidien, Interventional Lung Solutions. Mike was responsible for selling the superDimension Navigation System, a disruptive technology providing Pulmonologists and Thoracic Surgeons the ability to diagnose patients with early stage lung cancer.Before being acquired by Covidien, Mr. Blue held several leadership positions in superDimension as well as Boston Scientific, and started his career in consulting as an analyst for Andersen Consulting.
Rick Schefelker - Vice President, Engineering
Mr. Schefelker has a track record of developing and introducing over fifteen medical products to market with both GE Healthcare and Marquette Electronics. He has experience in FDA 510(k) medical development processes as well as in leading large engineering teams. Prior to joining NeuWave Medical, Mr. Schefelker was the Engineering Leader for Invasive Cardiology at GE Healthcare. A graduate of UW Madison, Mr. Schefelker has experience in software development and an understanding of both clinical cardiology and oncology.
Angela Gillespie - Vice President Marketing
Mrs. Gillespie brings 18-years of experience in strategic marketing experience to NeuWave, the last 13-years solely focused in the medical device industry. Prior to joining NeuWave, Mrs. Gillespie was most recently the Director of Covidien’s Peripheral Vascular Market Development team implementing strategic initiatives to grow Covidien’s endoarterial & endovenous businesses. Prior to her time at Covidien, Mrs. Gillespie served in several healthcare marketing agency leadership roles in partnership with leading medical device companies including Medtronic, Boston Scientific and Welch Allyn as well as several start-up companies including CardioDx, Calypso, Spiration, Fox Hollow, Asthmatx and Genomic Health to name a few. Angela’s experience spans the marketing spectrum and includes focused expertise in strategic market development, global commercial strategy development, international product launch and promotion, branding / messaging, sales training and execution, investor & public relations, alliance building, public education campaigns, patient advocacy and clinical trial recruitment and promotion.
Eric Clyse - Vice President, Operations
Mr. Clyse has over fifteen years of experience in supply chain management and the manufacturing of medical products. Most recently, he led Operations and Supply Chain for GE Ultrasound, and successfully introduced the Logiq E9 to market. Mr. Clyse was responsible for the startup of ultrasound manufacturing at the new GE Healthcare Research Park in Wauwatosa, WI. Since joining NeuWave, Mr. Clyse has led the establishment of the new 15,000 square foot facility and secured a strong, quality-focused supply base.
Ginger Sands - Vice President, Clinical Strategy & Education
Ms. Sands has over twenty years of experience in Sales, Clinical Support and Customer Experience roles in medical device businesses. During more than 15 years with Datex-Ohmeda and GE Healthcare, Ms. Sands built an extensive network with leading Academic institutions, and held multiple commercial leadership roles, most recently as a Territory Sales Manager for GE's Anesthesia business. Ms. Sands joined NeuWave in 2008, first building a best-in-class Customer Experience team and leading the market launch of the Certus 140. Ms. Sands has since developed and currently leads NeuWave's Clinical Support team, clinical education efforts and Academic partnerships.
Dan Kosednar - Director, Regulatory Affairs & Quality Assurance
Mr. Kosednar joined NeuWave from Datex-Ohmeda where he was responsible for regulatory strategy. During his tenure with Datex-Ohmeda, he successfully obtained sixteen 510(k) clearances. Mr. Kosednar has experience in designing and implementing compliant quality systems, and at NeuWave, he is responsible for ensuring that high quality processes are ingrained in all aspects of medical device development and manufacturing. Mr. Kosednar has held key quality and regulatory positions at both Datex-Ohmeda and Third Wave Technologies, and is also Regulatory Affairs certified.
Paul Laeseke, MD, PhD - Director, Clinical Affairs
Dr. Laeseke is a graduate of the University of Wisconsin Medical Scientist Training Program (combined MD/PhD degree program). His doctoral work focused on tumor ablation devices and techniques. He has extensive pre-clinical and clinical research experience related to tumor ablation. Dr. Laeseke has lectured nationally and internationally on tumor ablation. In addition, he has authored numerous manuscripts, book chapters, patents, and abstracts on the subject. He is currently a resident physician at Stanford University Medical Center, where he will also do his fellowship training in Interventional Radiology.